2024-02-26992.44 MB25页25
2024-02-261941.02 MB14页23
2024-02-26744.87 MB34页12
2024-02-26602.91 MB64页19
2024-02-261422.3 MB44页24
2024-02-26925.93 MB163页28
2024-02-261861.77 MB48页31
2024-02-261541.23 MB55页28
2024-02-261072.23 MB19页3
2024-02-267419.23 MB96页17
2024-02-261552.53 MB18页20
2024-02-26591.56 MB13页18
2024-02-26581.5 MB15页8
2024-02-26156892.15 KB5页1
2024-02-261614.3 MB51页2
2024-02-261293.26 MB47页3
2024-02-261487.68 MB25页10
2024-02-261836.48 MB906页19
2024-02-26982.75 MB12页7
2024-02-261973.82 MB28页22
![医药生物-2023年度中、美创新药获批情况跟踪报告：获批药物愈发多元化，本土创新力量不断迸发-兴业证券[孙媛媛]-20240221【25页】](http://www.bgcaijingpro.com/assets/images/load.png)
